Clinical Trial Tracker: A Spreadsheet Template & Its Limits

At a glance

• This page ships a real, structured clinical-trial / study tracker template, built around what a research site actually loses sleep over, not a generic grid.
• A good tracker tracks the things that cause findings: participant visit windows, consent versions, regulatory-binder currency, investigational product (IP) accountability, and screening-to-enrollment status.
• It also names the exact points where a spreadsheet quietly breaks: version chaos, no audit trail, two people overwriting each other, and manual status math.
• You can absolutely track in Excel today. The honest question is when the breakage starts costing you more than the tool would.
• Graduate when a spreadsheet can no longer give you a trustworthy, current, attributable picture, which usually arrives with more sites, more people, and real inspection exposure.

Search “clinical trial tracker” and you get template roundups that hand over a spreadsheet and stop. What they rarely do is tell you what a tracker should actually contain for a working site, or admit where a spreadsheet quietly fails. This page does both: it gives you a structured template built around real site pain, then tells the truth about when Excel stops being enough.

It serves two readers, the trial-ops lead and the study coordinator, because they share the same tracker. It is template-first and practical. For the seven-tracker oversight system, the timeline, and enrollment metrics specifically, see those dedicated guides; here the focus is the single working study tracker and the honest graduation question.

What a good tracker tracks

A generic grid tracks tasks. A good clinical-trial tracker tracks the things that actually go wrong at a site and show up as findings. Build it around these:

• Participant visit windows. Each participant’s scheduled visits and their allowed windows, so an out-of-window visit is caught before it happens, not after. Missed or out-of-window visits are a common deviation.
• Consent versions. Which consent form version each participant signed, and whether re-consent is needed after an amendment. A participant on an outdated consent version is a serious finding.
• Regulatory-binder currency. The status and currency of essential documents in the regulatory binder (approvals, CVs, training, delegation log), so the binder is inspection-ready, not reconstructed in a panic.
• IP / drug accountability. Investigational product received, dispensed, returned, and reconciled per participant, so accountability is continuous.
• Screening-to-enrollment status. Where each candidate is in the funnel (screened, screen-failed, enrolled), the operational pulse of the site.

These map to real GCP responsibilities. ICH E6(R3) requires investigators to maintain records of delegated activities (§ 2.3.3) and to document protocol deviations (§ 2.5.3), and it sets record-keeping and retention duties on the parties running the trial (§ 3.16.3). The tracker is where a site operationalizes those duties day to day; it does not replace the regulatory binder, but it keeps you on top of what the binder must contain.

The template

A workable study tracker is a small workbook with a sheet per domain:

Sheet	Key columns
Participants	Subject ID, status, consent version, enrollment date, current visit
Visit schedule	Subject ID, visit, target date, window, completed date, in/out of window
Consent log	Subject ID, consent version signed, date, re-consent needed?
Regulatory binder	Document, version, current?, expiry, owner
IP accountability	Lot, received, dispensed (per subject), returned, reconciled
Screening funnel	Candidate, screened date, result, enrolled date

A worked participant row, end to end: Subject 02-014, status Active, consent v2.1 signed 2026-01-20, enrolled 2026-01-22, currently at Visit 3, next visit due 2026-04-18 (window ±5 days), IP dispensed for Visits 1 to 3 and reconciled, no re-consent outstanding. That single row tells a coordinator everything they need to keep that participant compliant.

The same workbook serves two readers without duplication. The study coordinator lives in the participant, visit, consent, and IP sheets, the day-to-day operational record of keeping each participant on protocol. The trial-ops lead reads the summary roll-up across sites: how many enrolled, how many visits are at risk, which sites are behind. They are looking at one source of truth from two altitudes, which is exactly why the tracker has to stay current and consistent, a point that becomes the graduation question below.

Copy the sheet structure above into Excel to start today. The structure, built around real site risks, is what makes it more than a generic grid.

Managing it in Excel: setting it up well

A tracker built carelessly fails faster than one built with a little discipline. A few practices make a spreadsheet tracker hold up longer before you outgrow it:

• Use data-validation dropdowns for every status field. Status, consent version, in/out of window, and result should be picked from a fixed list, not free-typed. Free text (“active”, “Active”, “actv”) quietly breaks every count and filter you build on top of it.
• Name your ranges and keep one row per record. One participant per row, one visit per row on the visit sheet, no merged cells. Tidy, one-record-per-row tables are what let formulas and pivot tables roll up reliably; merged cells and multi-record rows are where roll-ups silently go wrong.
• Compute, don’t transcribe. Derive the in/out-of-window flag from the target date and the window with a formula, derive the screening funnel counts with COUNTIFS, and derive re-consent-needed from a comparison of signed version against current version. Every number a human retypes is a number that can drift out of sync.
• Put a status roll-up on its own summary sheet. A single sheet that counts participants by status, flags any visit out of window, and lists any participant on an outdated consent version turns the workbook from a record into a dashboard you can read in ten seconds.
• Protect the structure and date your file. Lock the formula cells so a hurried edit cannot overwrite them, and put the last-updated date where everyone can see it, so no one acts on a week-old copy.

None of this turns Excel into a validated system, and that is the point of the next two sections. It does, however, buy a small team real runway before the spreadsheet’s limits start to bite.

Where spreadsheets break

Be honest about the limits, because they are real and they bite at the worst moment:

• Version chaos. Multiple copies (tracker_final, tracker_v2, tracker_USE-THIS) with no single source of truth, so people work from stale data.
• No audit trail. A spreadsheet does not reliably record who changed what and when, so you cannot reconstruct the history of an entry, exactly what an inspector may ask for.
• Concurrent overwrites. Two people edit the same workbook and one person’s changes vanish silently.
• Manual status math. Counts, windows, and reconciliations computed by hand drift out of sync and introduce errors.

None of these are reasons to never use a spreadsheet; they are reasons to know its ceiling.

The graduation question: when to upgrade

You have outgrown a spreadsheet tracker when it can no longer give you a picture that is current, trustworthy, and attributable. Concretely, when:

• More than one or two people need to update it concurrently.
• You are running multiple sites and the version chaos is real.
• You cannot produce, on demand, a reliable status or a history of who changed what.
• Inspection exposure means the missing audit trail is now a genuine risk.

At that point the spreadsheet is no longer the cheap option; the time spent reconciling it, and the risk it carries, exceed the cost of a purpose-built tool. The graduation step for a lean team is usually not an enterprise CTMS but a right-sized clinical project management tool that gives the tracker a single source of truth, concurrent access, and an audit trail. TrialTrack is one such option: it centralizes this kind of tracking with role-based access and a built-in audit trail for small teams (its vendor’s own Part 11-aligned claim; no tool makes a site compliant). It is a coordination tool, not an EDC or eTMF, so it complements the regulatory systems rather than replacing them.

Frequently asked questions

What should a clinical trial tracker track? The things that actually cause findings at a site: participant visit windows, consent versions, regulatory-binder currency, IP/drug accountability, and screening-to-enrollment status, not just generic tasks.

Can I run a trial tracker in Excel? Yes, especially for a single small study. Build it around the real site risks above. Just know where it breaks.

Where do spreadsheet trackers break? Version chaos, no audit trail, concurrent overwrites, and manual status math, all of which undermine a current, trustworthy, attributable picture.

When should I upgrade from a spreadsheet? When you cannot keep the tracker current, trustworthy, and attributable, typically once multiple people and sites are involved and inspection exposure makes the missing audit trail a real risk.

Does a tracker replace the regulatory binder? No. The tracker helps you stay on top of what the binder must contain (and flags currency), but the essential documents and their retention remain their own obligation.

The bottom line

A clinical trial tracker is worth having only if it tracks what actually goes wrong, visit windows, consent versions, binder currency, IP accountability, screening status, so build it around those, not a generic grid. Run it in Excel today, but know exactly where spreadsheets break, and graduate to a tool with a single source of truth and an audit trail when you can no longer keep the picture current, trustworthy, and attributable.

Sources

• ICH E6(R3) Good Clinical Practice